0 items USD 0.00Search
- Did you mean
- crohn disease
Your search for "Crohn’s disease" gave back 10774 results.
The global Remicade (Infliximab) Monoclonal Antibody market size is projected to grow from US$ 2494.5 million in 2022 to US$ 3703.9 million in 2029;...
Catalog:
LPI
June 2023
Price: USD 3,660.00
The global Remicade (Infliximab) Monoclonal Antibody market size is expected to reach $ 3781.3 million by 2029, rising at a market growth of 5.4%...
Catalog:
GIR
June 2023
Price: USD 4,480.00
The global Humira market size was valued at US$ 16700 million in 2023. With growing demand in downstream market, the Humira is forecast to a...
Catalog:
LPI
January 2024
Price: USD 3,660.00
Humira (adalimumab) is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation. Humira...
Catalog:
GIR
April 2023
Price: USD 3,480.00
Inflammatory bowel disease is a condition generally caused when immune system attacks harmless bacteria, virus, or food in the intestine. The most...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Smart pill technology is a revolutionary technological innovation that has reduced the gap between healthcare and digital technology. Smart pills or...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
The global Humira market size was valued at USD 17560 million in 2023 and is forecast to a readjusted size of USD 9840.6 million by 2030 with a CAGR...
Catalog:
GIR
January 2024
Price: USD 3,480.00
Inflammatory bowel disease is a group of medical conditions that causes chronic inflammation in the digestive tract. The inflammatory bowel disease...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Inflammatory bowel disease is a group of medical conditions that causes chronic inflammation in the digestive tract. The inflammatory bowel disease...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
The global Remicade (Infliximab) Monoclonal Antibody market size was valued at USD 2623.8 million in 2022 and is forecast to a readjusted size of USD...
Catalog:
GIR
June 2023
Price: USD 3,480.00
Inflammatory bowel disease is a group of medical conditions that causes chronic inflammation in the digestive tract. The inflammatory bowel disease...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Certolizumab pegol (CDP870, tradename Cimzia) is a biologic medication for the treatment of Crohn's disease, rheumatoid arthritis, psoriatic...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Inflammatory bowel disease is a condition generally caused when immune system attacks harmless bacteria, virus, or food in the intestine. The most...
Catalog:
GIR
January 2023
Price: USD 3,480.00
Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Inflammatory bowel disease is a group of medical conditions that causes chronic inflammation in the digestive tract. The inflammatory bowel disease...
Catalog:
GIR
February 2023
Price: USD 3,480.00
